Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Abacavir
Active Ingredient: Abacavir sulfate 351.39mg equivalent to 300mg abacavir
Dosage Form: Film coated tablet
New Zealand Sponsor: REX Medical Limited
Manufacturer: Cipla Limited, Maharashtra, India
Product: Univent
Active Ingredient: Ipratropium bromide monohydrate 0.0313%w/v
Dosage Form: Nasal spray solution
New Zealand Sponsor: REX Medical Limited
Manufacturer: Cipla Limited, Salcette, India
Dated this 20th day of August 2010.
JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).